Magellan Health Statistics Share Statistics Magellan Health has 0
shares outstanding. The number of shares has increased by null%
in one year.
Shares Outstanding n/a Shares Change (YoY) n/a Shares Change (QoQ) n/a Owned by Institutions (%) n/a Shares Floating n/a Failed to Deliver (FTD) Shares n/a FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 1.09M, so 0% of the outstanding
shares have been sold short.
Short Interest 1.09M Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 6.33
Valuation Ratios The PE ratio is 527.85 and the forward
PE ratio is null.
Magellan Health's PEG ratio is
-5.68.
PE Ratio 527.85 Forward PE n/a PS Ratio 0.47 Forward PS n/a PB Ratio 1.14 P/FCF Ratio 5.69 PEG Ratio -5.68
Financial Ratio History Enterprise Valuation Magellan Health has an Enterprise Value (EV) of 1.63B.
EV / Sales 0.36 EV / EBITDA 3.34 EV / EBIT 3.62 EV / FCF 4.34
Financial Position The company has a current ratio of 2.92,
with a Debt / Equity ratio of 0.34.
Current Ratio 2.92 Quick Ratio 2.86 Debt / Equity 0.34 Debt / EBITDA 1.31 Debt / FCF 1.7 Interest Coverage 11.94
Financial Efficiency Return on Equity is 0.22% and Return on Invested Capital is -1.4%.
Return on Equity 0.22% Return on Assets 0.12% Return on Invested Capital -1.4% Revenue Per Employee $508.61K Profits Per Employee $449.56 Employee Count 9,000 Asset Turnover 1.36 Inventory Turnover 102.89
Taxes Income Tax -44.53M Effective Tax Rate 109.99%
Stock Price Statistics The stock price has increased by 0% in the
last 52 weeks. The beta is 1.04, so Magellan Health's
price volatility has been higher than the market average.
Beta 1.04 52-Week Price Change n/a 50-Day Moving Average n/a 200-Day Moving Average n/a Relative Strength Index (RSI) n/a Average Volume (20 Days) 143,016
Income Statement In the last 12 months, Magellan Health had revenue of 4.58B
and earned 4.05M
in profits. Earnings per share was 0.16.
Revenue 4.58B Gross Profit 118.79M Operating Income 368.67M Net Income 4.05M EBITDA 487.41M EBIT -9.62M Earnings Per Share (EPS) 0.16
Full Income Statement Balance Sheet The company has 1.14B in cash and 638.38M in
debt, giving a net cash position of 506.07M.
Cash & Cash Equivalents 1.14B Total Debt 638.38M Net Cash 506.07M Retained Earnings 1.86B Total Assets n/a Working Capital n/a
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 450.76M
and capital expenditures -75.48M, giving a free cash flow of 375.28M.
Operating Cash Flow 450.76M Capital Expenditures -75.48M Free Cash Flow 375.28M FCF Per Share 14.56
Full Cash Flow Statement Margins Gross margin is 2.6%, with operating and profit margins of 8.05% and 0.09%.
Gross Margin 2.6% Operating Margin 8.05% Pretax Margin -0.88% Profit Margin 0.09% EBITDA Margin 10.65% EBIT Margin 8.05% FCF Margin 8.2%
